Tina St. Leger
Vermögen: 37 833 $ am 31.07.2026
Vermögen: 37 833 $ am 31.07.2026
Tina St. Leger is Chief People Officer at Oxford Nanopore Technologies Plc since 2026.
Former roles include Chief Human Resources Officer & Executive VP at Immunocore Holdings Plc from 2022 to 2026, Chief Human Resource Officer at GW Pharmaceuticals Ltd. from 2019 to 2021, Head-Human Resources at ViiV Healthcare Ltd. from 2012 to 2016, Vice President-Therapeutic Groups at GSK Plc, and Head-Leadership & Development at Marks & Spencer Plc.
Education includes an undergraduate degree from the University of St. Andrews.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2026 | 1.119 ( 0 % ) | 37 833 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Personalreferent | 01.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Personalreferent | 26.05.2026 |
| GW PHARMACEUTICALS PLC | Personalreferent | 01.12.2021 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Personalreferent | 01.06.2016 |
Marks & Spencer Plc
Marks & Spencer Plc Department StoresRetail Trade Operates department stores | Corporate Officer/Principal | - |
| GSK PLC | Personalreferent | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Marks & Spencer Plc
Marks & Spencer Plc Department StoresRetail Trade Operates department stores | Retail Trade |
Oxford Nanopore Technologies Plc
Oxford Nanopore Technologies Plc Electronic Equipment/InstrumentsElectronic Technology Develops instruments for electronic detection and analysis of molecules | Electronic Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
University of St. Andrews
University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen